Report Detail

Pharma & Healthcare COVID-19 Impact on Global Oral Rotavirus Vaccine, Market Insights and Forecast to 2026

  • RnM4079187
  • |
  • 25 June, 2020
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Oral Rotavirus Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Rotavirus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Oral Rotavirus Vaccine market is segmented into
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb

Segment by Application, the Oral Rotavirus Vaccine market is segmented into
Hospital
Vaccination Station
Other

Regional and Country-level Analysis
The Oral Rotavirus Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Rotavirus Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Rotavirus Vaccine Market Share Analysis
Oral Rotavirus Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Rotavirus Vaccine business, the date to enter into the Oral Rotavirus Vaccine market, Oral Rotavirus Vaccine product introduction, recent developments, etc.
The major vendors covered:
GSK
Sanofi-Pasteur
Merck
Biological E. Limited
China National Biotec Group
Sinovac Biotech
...


1 Study Coverage

  • 1.1 Oral Rotavirus Vaccine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Oral Rotavirus Vaccine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Oral Rotavirus Vaccine Market Size Growth Rate by Type
    • 1.4.2 Rotarix
    • 1.4.3 RotaTeq
    • 1.4.4 Rotavac
    • 1.4.5 Rotavin-M1
    • 1.4.6 Lanzhou lamb
  • 1.5 Market by Application
    • 1.5.1 Global Oral Rotavirus Vaccine Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Vaccination Station
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Oral Rotavirus Vaccine Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Oral Rotavirus Vaccine Industry
      • 1.6.1.1 Oral Rotavirus Vaccine Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Oral Rotavirus Vaccine Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Oral Rotavirus Vaccine Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Oral Rotavirus Vaccine Market Size Estimates and Forecasts
    • 2.1.1 Global Oral Rotavirus Vaccine Revenue 2015-2026
    • 2.1.2 Global Oral Rotavirus Vaccine Sales 2015-2026
  • 2.2 Oral Rotavirus Vaccine Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Oral Rotavirus Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Oral Rotavirus Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Oral Rotavirus Vaccine Competitor Landscape by Players

  • 3.1 Oral Rotavirus Vaccine Sales by Manufacturers
    • 3.1.1 Oral Rotavirus Vaccine Sales by Manufacturers (2015-2020)
    • 3.1.2 Oral Rotavirus Vaccine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Oral Rotavirus Vaccine Revenue by Manufacturers
    • 3.2.1 Oral Rotavirus Vaccine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Oral Rotavirus Vaccine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Oral Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Oral Rotavirus Vaccine Revenue in 2019
    • 3.2.5 Global Oral Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Oral Rotavirus Vaccine Price by Manufacturers
  • 3.4 Oral Rotavirus Vaccine Manufacturing Base Distribution, Product Types
    • 3.4.1 Oral Rotavirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Oral Rotavirus Vaccine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Oral Rotavirus Vaccine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Oral Rotavirus Vaccine Market Size by Type (2015-2020)
    • 4.1.1 Global Oral Rotavirus Vaccine Sales by Type (2015-2020)
    • 4.1.2 Global Oral Rotavirus Vaccine Revenue by Type (2015-2020)
    • 4.1.3 Oral Rotavirus Vaccine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Oral Rotavirus Vaccine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Oral Rotavirus Vaccine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Oral Rotavirus Vaccine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Oral Rotavirus Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Oral Rotavirus Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Oral Rotavirus Vaccine Market Size by Application (2015-2020)
    • 5.1.1 Global Oral Rotavirus Vaccine Sales by Application (2015-2020)
    • 5.1.2 Global Oral Rotavirus Vaccine Revenue by Application (2015-2020)
    • 5.1.3 Oral Rotavirus Vaccine Price by Application (2015-2020)
  • 5.2 Oral Rotavirus Vaccine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Oral Rotavirus Vaccine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Oral Rotavirus Vaccine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Oral Rotavirus Vaccine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Oral Rotavirus Vaccine by Country
    • 6.1.1 North America Oral Rotavirus Vaccine Sales by Country
    • 6.1.2 North America Oral Rotavirus Vaccine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Oral Rotavirus Vaccine Market Facts & Figures by Type
  • 6.3 North America Oral Rotavirus Vaccine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Oral Rotavirus Vaccine by Country
    • 7.1.1 Europe Oral Rotavirus Vaccine Sales by Country
    • 7.1.2 Europe Oral Rotavirus Vaccine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Oral Rotavirus Vaccine Market Facts & Figures by Type
  • 7.3 Europe Oral Rotavirus Vaccine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Oral Rotavirus Vaccine by Region
    • 8.1.1 Asia Pacific Oral Rotavirus Vaccine Sales by Region
    • 8.1.2 Asia Pacific Oral Rotavirus Vaccine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Oral Rotavirus Vaccine Market Facts & Figures by Type
  • 8.3 Asia Pacific Oral Rotavirus Vaccine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Oral Rotavirus Vaccine by Country
    • 9.1.1 Latin America Oral Rotavirus Vaccine Sales by Country
    • 9.1.2 Latin America Oral Rotavirus Vaccine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Oral Rotavirus Vaccine Market Facts & Figures by Type
  • 9.3 Central & South America Oral Rotavirus Vaccine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Oral Rotavirus Vaccine by Country
    • 10.1.1 Middle East and Africa Oral Rotavirus Vaccine Sales by Country
    • 10.1.2 Middle East and Africa Oral Rotavirus Vaccine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Oral Rotavirus Vaccine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Oral Rotavirus Vaccine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GSK
    • 11.1.1 GSK Corporation Information
    • 11.1.2 GSK Description, Business Overview and Total Revenue
    • 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GSK Oral Rotavirus Vaccine Products Offered
    • 11.1.5 GSK Recent Development
  • 11.2 Sanofi-Pasteur
    • 11.2.1 Sanofi-Pasteur Corporation Information
    • 11.2.2 Sanofi-Pasteur Description, Business Overview and Total Revenue
    • 11.2.3 Sanofi-Pasteur Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Sanofi-Pasteur Oral Rotavirus Vaccine Products Offered
    • 11.2.5 Sanofi-Pasteur Recent Development
  • 11.3 Merck
    • 11.3.1 Merck Corporation Information
    • 11.3.2 Merck Description, Business Overview and Total Revenue
    • 11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Merck Oral Rotavirus Vaccine Products Offered
    • 11.3.5 Merck Recent Development
  • 11.4 Biological E. Limited
    • 11.4.1 Biological E. Limited Corporation Information
    • 11.4.2 Biological E. Limited Description, Business Overview and Total Revenue
    • 11.4.3 Biological E. Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Biological E. Limited Oral Rotavirus Vaccine Products Offered
    • 11.4.5 Biological E. Limited Recent Development
  • 11.5 China National Biotec Group
    • 11.5.1 China National Biotec Group Corporation Information
    • 11.5.2 China National Biotec Group Description, Business Overview and Total Revenue
    • 11.5.3 China National Biotec Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 China National Biotec Group Oral Rotavirus Vaccine Products Offered
    • 11.5.5 China National Biotec Group Recent Development
  • 11.6 Sinovac Biotech
    • 11.6.1 Sinovac Biotech Corporation Information
    • 11.6.2 Sinovac Biotech Description, Business Overview and Total Revenue
    • 11.6.3 Sinovac Biotech Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Sinovac Biotech Oral Rotavirus Vaccine Products Offered
    • 11.6.5 Sinovac Biotech Recent Development
  • 11.1 GSK
    • 11.1.1 GSK Corporation Information
    • 11.1.2 GSK Description, Business Overview and Total Revenue
    • 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GSK Oral Rotavirus Vaccine Products Offered
    • 11.1.5 GSK Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Oral Rotavirus Vaccine Market Estimates and Projections by Region
    • 12.1.1 Global Oral Rotavirus Vaccine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Oral Rotavirus Vaccine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Oral Rotavirus Vaccine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Oral Rotavirus Vaccine Sales Forecast (2021-2026)
    • 12.2.2 North America: Oral Rotavirus Vaccine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Oral Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Oral Rotavirus Vaccine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Oral Rotavirus Vaccine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Oral Rotavirus Vaccine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Oral Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Oral Rotavirus Vaccine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Oral Rotavirus Vaccine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Oral Rotavirus Vaccine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Oral Rotavirus Vaccine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Oral Rotavirus Vaccine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Oral Rotavirus Vaccine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Oral Rotavirus Vaccine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Oral Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Oral Rotavirus Vaccine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Oral Rotavirus Vaccine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Oral Rotavirus Vaccine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Oral Rotavirus Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Oral Rotavirus Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Oral Rotavirus Vaccine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Oral Rotavirus Vaccine. Industry analysis & Market Report on COVID-19 Impact on Global Oral Rotavirus Vaccine is a syndicated market report, published as COVID-19 Impact on Global Oral Rotavirus Vaccine, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Oral Rotavirus Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,112.20
    4,668.30
    6,224.40
    3,642.60
    5,463.90
    7,285.20
    609,453.00
    914,179.50
    1,218,906.00
    325,611.00
    488,416.50
    651,222.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report